Antifungal Activity of Xanthones: Evaluation of their Effect on Ergosterol Biosynthesis by High-performance Liquid Chromatography

Chemical Biology and Drug Design

Volumn 77, Issue 3, 2011, Pages 212-222

  Pinto, Eugénia ^a   Afonso, Carlos ^a   Duarte, Serafim ^a   Vale Silva, Luís ^a   Costa, Elisangela ^a   Sousa, Emília ^a   Pinto, Madalena ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antifungal; Aspergillus; Candida; Cryptococcus; Dermatophytes; Ergosterol; Xanthone

Indexed keywords

1 METHOXYXANTHONE; 1,2 DIHYDROXYXANTHONE; 1,2,8 TRIMETHOXYXANTHONE; 2 HYDROXY 1,8 DIMETHOXYXANTHONE; 2 HYDROXYXANTHONE; 2,3 DIHYDROXYXANTHONE; 3 HYDROXYXANTHONE; 3,4 DIHYDROXYXANTHONE; 3,5 DIMETHOXYXANTHONE; 3,6 DIHYDROXYXANTHONE; 4 HYDROXYXANTHONE; ERGOSTEROL; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG EFFECT; FUNGAL CELL; FUNGAL STRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RADIATION DETECTION; STEROL SYNTHESIS; TRICHOPHYTON MENTAGROPHYTES; ULTRAVIOLET RADIATION; VALIDATION PROCESS; WHOLE CELL;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CANDIDA ALBICANS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYPTOCOCCUS NEOFORMANS; ERGOSTEROL; MICROBIAL SENSITIVITY TESTS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TRICHOPHYTON; XANTHONES;

ARTHRODERMA BENHAMIAE; ARTHRODERMATACEAE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANDIDA; CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 79651474308     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2010.01072.x     Document Type: Article

References (70)

1. Groll A.H., De Lucca A.J., Walsh T.J. (1998) Emerging targets for the development of novel antifungal therapeutics. Trends Microbiol;6:117-124.
2. Richardson M.D. (2005) Changing patterns and trends in systematic fungal infections. J Antimicrobiol Chemother;56:5-11.
3. Gupta A.K., Tu L.Q. (2006) Dermatophytes: diagnosis and treatment. J Am Acad Dermatol;54:1050-1055.
4. Johnson L. (2003) Dermatophytes-the skin eaters. Mycologist;17:147-149.
5. Sundriyal S., Sharma R.K., Jain R. (2006) Current advances in antifungal targets and drug development. Curr Med Chem;13:1321-1335.
6. Odds F.C. (2003) Antifungal agents: their diversity and increasing sophistication. Mycologist;17:51-55.
7. Pinto M.M.M., Sousa E., Nascimento M.S.J. (2005) Xanthone derivatives: new insights in biological activities. Curr Med Chem;12:2517-2538.
8. Marona H., Szkaradek N., Karczewska E., Trojanowska D., Budak A., Bober P., Przepirka W., Cegla M., Szneler E. (2009) Antifungal and antibacterial activity of the newly synthesized 2-xanthone derivatives. Arch Pharm (Weinheim);342:9-18.
9. Gopalakrishnan G., Banumathi B., Suresh G.J. (1997) Evaluation of the antifungal activity of natural xanthones from Garcinia mangostana and their synthetic derivatives. J Nat Prod;60:519-524.
10. Azebaze A.G.B., Ouahouo B.M.W., Vardamides J.C., Valentin A., Kuete V., Acebey L., Bengd V.P., Nkengfack A.E., Meyer M. (2008) Antimicrobial and antileishmanial xanthones from the stem bark of Allanblackia gabonensis (Guttiferae). Nat Prod Res;22:333-341.
11. Boonnak N., Chatchanok K., Chantrapromma S., Ponglimanont C., Fun H.-K., Opas A.K., Chantrapromma K., Kato S. (2009) Anti-Pseudomonas aeruginosa xanthones from the resin and green fruits of Cratoxylum cochinchinense. Tetrahedron;65:3003-3013.
12. Cortez D.A.G., Young M.C.M., Marston A., Wolfender J.-L., Hostettmann K. (1998) Xanthones, triterpenes and a biphenyl from Kielmeyera coriacea. Phytochemistry;47:1367-1374.
13. Fukai T., Yonekawa M., Hou A.-J., Nomura T., Sun H.-D., Uno J. (2003) Antifungal agents from the roots of Cudrania cochinchinensis against Candida, Cryptococcus, and Aspergillus species. J Nat Prod;66:1118-1120.
14. Han Q.-B., Qiao C.-F., Song J.-Z., Yang N.-Y., Cao X.-W., Peng-Yu Y., Yang D.-J., Chen S.-L., Xu H.-X. (2007) Cytotoxic prenylated phenolic compounds from the twig bark of Garcinia xanthochymus. Chem Biodivers;4:940-946.
15. Hay A.E., Guilet D., Morel C., Larcher G., Macherel D., Le Ray A.M., Litaudon M., Richomme P. (2003) Antifungal chromans inhibiting the mitochondrial respiratory chain of pea seeds and new xanthones from Calophyllum caledonicum. Planta Med;69:1130-1135.
16. Kuete V., Nguemevin J.R., Beng V.P., Azebaze A.G.B., Etoa F.-X., Meyer M., Bodo B., Nkengfack A.E. (2007) Antimicrobial activity of the methanolic extracts and compounds from Vismia laurentii De Wild (Guttiferae). J Ethnopharmacol;109:372-379.
17. Morel C., Hay A.E., Litaudon M., Sévenet T., Séraphin T.D., Bruneton J., Richomme P. (2002) Thirteen new xanthone derivatives from Calophyllum caledonicum (Clusiaceae). Molecules;7:38-50.
18. Morel C., Seraphin D., Teyrouz A., Larcher G., Bouchara J.P., Litaudon M., Richomme P., Bruneton J. (2002) New and antifungal xanthones from Calophyllum caledonicum. Planta Med;6:41-44.
19. Pinto D.C., Fuzzati N., Pazmino X.C., Hostettmann K. (1994) Xanthone and antifungal constituents from Monnina obtusifolia. Phytochemistry;37:875-878.
20. Rath G., Potterat O., Mavi S., Hostettmann K. (1996) Xanthones from Hypericum roeperanum. Phytochemistry;43:513-520.
21. Reyes-Chilpa R., Jimenez-Estrada M., Estrada-Muñiz E. (1997) Antifungal xanthones from Calophyllum brasiliensis heartwood. J Chem Ecology;23:1901-1911.
22. Rocha L., Marston A., Kaplan M.A., Stoeckli-Evans H., Thull U., Testa B., Hostettmann K. (1994) An antifungal gamma-pyrone and xanthones with monoamine oxidase inhibitory activity from Hypericum brasiliense. Phytochemistry;36:1381-1385.
23. Salmoiraghi I., Rossi M., Valenti P., Da Re P. (1998) Allylamine type xanthone antimycotics. Arch Pharm (Weinheim);331:225-227.
24. Sordat-Diserens I., Rogers C., Sordat B., Hostettmann K. (1992) Prenylated xanthones from Garcinia livingstonei. Phytochemistry;31:313-316.
25. Tene M., Tane P., Kuiate J.-R., Tamokou J.D., Connolly J.D. (2008) Anthocleistenolide, a new rearranged nor-secoiridoid derivative from the stem bark of Anthocleista vogelii. Planta Med;74:80-83.
26. Zhang Z., ElSohly H.N., Jacob M.R., Pasco D.S., Walker L.A., Clark A.M. (2002) Natural products inhibiting Candida albicans secreted aspartic proteases from Tovomita krukovii. Planta Med;68:49-54.
27. Chu M., Truumees I., Mierzwa R., Terracciano J., Patel M., Loebenberg D., Kaminski J.J., Das P., Puar M.S. (1997) Sch 54445: a new polycyclic xanthone with highly potent antifungal activity produced by Actinoplanes sp. J Nat Prod;60:525-528.
28. Chu M., Truumees I., Mierzwa R., Terracciano J., Patel M., Das P.R., Puar M.S., Chan T.-M. (1998) A new potent antifungal agent from Actinoplanes sp. Tetrahedron Lett;39:7649-7653.
29. Kobayashi K., Nishino C., Ohya J., Sato S., Mikawa T., Shiobara Y., Kodama M.J. (1988) Actinoplanones C, D, E, F and G, new cytotoxic polycyclic xanthones from Actinoplanes sp. J Antibiot;41:741-750.
30. Isaka M., Palasarn S., Auncharoen P., Komwijit S., Jones E.B.G. (2009) Acremoxanthones A and B, novel antibiotic polyketides from the fungus Acremonium sp. BCC 31806. Tetrahedron Lett;50:284-287.
31. Lösgen S., Magull J., Schulz B., Draeger S., Zeeck A. (2008) Isofusidienols: novel chromone-3-oxepines produced by the endophytic fungus Chalara sp. Eur J Org Chem;4:698-703.
32. Overy D., Calati K., Kahn J.N., Hsu M.-J., Martín J., Collado J., Roemer T., Harris G., Parish C.A. (2009) Isolation and structure elucidation of parnafungins C and D, isoxazolidinone-containing antifungal natural products. Bioorg Med Chem Lett;19:1224-1227.
33. Parish C.A., Smith S.K., Calati K., Zink D., Wilson K., Roemer T., Jiang B. et al. (2008) Isolation and structure elucidation of parnafungins, antifungal natural products that inhibit mRNA polyadenylation. J Am Chem Soc;130:7060-7066.
34. Zhang W., Krohn K., Ullah Z., Flçrke U., Pescitelli G., Di Bari L., Antus S., Kurtán T., Rheinheimer J., Draeger S., Schulz B. (2008) New mono- and dimeric members of the secalonic acid family: Blennolides A G isolated from the fungus Blennoria sp. Chem Eur J;14:4913-4923.
35. Abdel-Lateff A., Klemke C., Konig G.M., Wright A.D. (2003) Two new xanthone derivatives from the algicolous marine fungus Wardomyces anomalus. J Nat Prod;66:706-708.
36. Höller U., König G.M., Wright A.D. (1999) A new tyrosine kinase inhibitor from a marine isolate of Ulocladium botrytis and new metabolites from the marine fungi Asteromyces cruciatus and Varicosporina ramulosa. Eur J Org Chem;11:2949-2955.
37. Castanheiro R.A.P., Pinto M.M.M., Silva A.M.S., Cravo S.M.M., Gales L., Damas A.M., Nazareth N., Nascimento M.S.J., Eaton G. (2007) Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7. Bioorg Med Chem;15:6080-6088.
38. Pedro M., Cerqueira F., Sousa M.E., Nascimento M.S.J., Pinto M.M.M. (2002) Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. Bioorg Med Chem;10:3725-3730.
39. Sousa E., Silva A.M.S., Pinto M.M.M., Pedro M.M., Cerqueira F.A.M., Nascimento M.S.J. (2002) Isomeric kielcorins and dihydroxyxanthones: synthesis, structure elucidation and inhibitory activities of growth of human cancer cell lines and on the proliferation of human lymphocytes in vitro. Helv Chim Acta;85:2862-2876.
40. Sousa E., Paiva A., Nazareth N., Gales L., Damas A.M., Nascimento M.S.J., Pinto M.M.M. (2009) Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines. Eur J Med Chem;44:3830-3835.
41. Gonzalez M.J., Nascimento M.S.J., Cidade H.M., Pinto M.M.M., Kijjoa A., Anantachoke C., Silva A.M.S., Herz W. (1999) Immunomodulatory activity of xanthones from Calophyllum teysmannii var. inophylloide. Planta Med;65:368-371.
42. Pinto M.M.M., Nascimento M.S.J., Gonzalez M.J., Mondranondra I.O. (1997) Anticomplementary activity and constituents of Cratoxylum maingayi DYER. Pharm Pharmacol Lett;7:128-130.
43. Pinto M.M.M., Nascimento M.S.J. (1997) Anticomplementary activity of hydroxy- and methoxyxanthones. Pharm Pharmacol Lett;7:125-127.
44. Saraiva L., Fresco P., Pinto E., Sousa E., Pinto M.M.M., Gonçalves J. (2002) Synthesis and in vivo modulatory activity of protein kinase C of xanthone derivatives. Bioorg Med Chem;10:3219-3227.
45. Saraiva L., Fresco P., Pinto E., Sousa E., Pinto M.M.M., Gonçalves J. (2003) Inhibition of a, bI, d, h, and z PKC isoforms by xanthonolignoids. J Enzyme Inhib Med Chem;18:357-370.
46. Saraiva L., Fresco P., Pinto E., Sousa E., Pinto M.M.M., Gonçalves J. (2003) Inhibition of protein kinase C by synthetic xanthone derivatives. Bioorg Med Chem;11:1215-1225.
47. Portela C., Afonso C.M.M., Pinto M.M.M., Lopes D., Nogueira F., Rosario V. (2007) Synthesis and antimalarial properties of new chloro-9h-xanthones with an aminoalkyl side chain. Chem Biodivers;4:1508-1519.
48. Fernandes E.R., Carvalho F.D., Remião F.G., Bastos M.L., Pinto M.M.M., Gottlieb O.R. (1995) Hepatoprotective activity of xanthones and xanthonolignoids against tetra-butylhydroperoxide-induced toxicity in rat isolated hepatocytes- comparison with silybin. Pharm Res;12:1756-1760.
49. Gnerre C., Thull U., Gaillar P., Carrupt P.A., Testa B., Fernandes E., Silva F., Pinto M.M.M., Wolfender J.L., Hostettman K., Cruciani G. (2001) Natural and synthetic xanthones as monoamine oxidase inhibitors: biological assay and 3D-QSAR. Helv Chim Acta;84:552-570.
50. Thull U., Kneubuhler S., Testa B., Borges M.F., Pinto M.M.M. (1993) Substituted xanthones as selective and reversible MAO-A inhibitors. Pharmacol Res;10:1187-1190.
51. Sanati H., Belanger P., Fratti R., Ghannoum M. (1997) A new triazole, voriconazole (uk-109, 496), blocks sterol biosynthesis in Candida krusei. Antimicrob Agents Chemother;41:2492-2496.
52. Kijjoa A., Gonzalez M.J., Afonso C.M., Pinto M.M.M., Anantachoke C., Herz W. (1999) Xanthones from Calophylum teysmannii var. inophylloide. Phytochemistry;53:1021-1024.
53. Gales L., Sousa E., Pinto M.M.M., Kijjoa A., Damas A.M. (2001) Naturally occurring 1, 2, 8-trimethoxyxanthone and biphenyl ether intermediates leading to 1, 2-dimethoxyxanthone. Acta Crystallogr Sect C;57:1319-1323.
54. National Committee for Clinical Laboratory Standards. (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved Standard M27A2. Wayne, Pa: National Committee for Clinical Laboratory Standards.
55. National Committee for Clinical Laboratory Standards (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, Approved Standard M38A. Wayne, Pa: National Committee for Clinical Laboratory Standards.
56. Arthington-Skaggs B.A., Jradi H., Desai T., Morrison C.J. (1999) Quantification of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol;37:3332-3337.
57. Peacock G.A., Goosey M.W. (1989) Separation of fungal sterols by normal-phase high-performance liquid chromatography: Application to the evaluation of ergosterol biosynthesis inhibitors. J Chromatogr A;469:293-304.
58. International Conference Harmonization (1995) ICH/381/95 Validation of Analytical Procedures: Text and Methodology. Committee for Medicinal Products for Human Use, London, UK.
59. Sousa E., Pinto M.M.M. (2005) Synthesis of xanthones: an overview. Curr Med Chem;12:2447-2479.
60. Ellis R.C., Whalley W.B., Ball K. (1976) The chemistry of fungi. Part LXX. Synthesis of some xanthones. J Chem Soc;13:1377-1381.
61. Quillinan A.J., Scheinmann F. (1973) Studies in the xanthone series. Part XII. A general synthesis of polyoxygenated xanthones from benzophenone precursors. J Chem Soc Perkin Trans;1(2):1329-1337.
62. Fotie J., Bohle S. (2006) Pharmacological and biological activities of xanthones. Curr Med Chem Anti-Infective Agents;5:15-31.
63. Pinto M.M.M., Castanheiro R. (2009) Natural prenylated xanthones: chemistry and biological activities. In: Brahmachari G., editor. Natural Products Chemistry, Biochemistry and Pharmacology. Bengal, India: Narosa publishing house PVT. LTD; p. 520-675.
64. Larcher G., Morel C., Tronchin G., Landreau A., Seraphin D., Richomme P., Bouchara J.P. (2004) Investigation of the Antifungal Activity of Caledonixanthone E and Other Xanthones Against Aspergillus fumigatus. Planta Med;70:569-571.
65. Pauli A. (2006) Anticandidal Low Molecular Compounds from Higher Plants with Special Reference to Compounds from Essential Oils. Med Res Rev;26:223-268.
66. Madan B., Singh I., Kumar A., Prasad A.K., Raj H.G., Parmar V.S., Ghosh B. (2002) Xanthones as inhibitors of microsomal lipid peroxidation and TNF-α induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs). Bioorg Med Chem;10:3431-3436.
67. Lee B.W., Lee J.H., Lee S.-T., Lee H.S., Lee W.S., Jeong T.S., Park K.H. (2005) Antioxidant and cytotoxic activities of xanthones from Cudrania tricuspidata. Bioorg Med Chem Lett;15:5548-5552.
68. Tsuchiya H., Iinuma M. (2000) Reduction of membrane fluidity by antibacterial sophoraflavanone G isolated from Sophora exigua. Phytomed;7:161-165.
69. Ibrahim A.S., Edwards J.E. Jr, Fu Y., Spellberg B. (2006) Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother;58:1070-1073.
70. Zarember K.A., Cruz A.R., Huang C.-Y., Gallin J.I. (2009) Antifungal Activities of Natural and Synthetic Iron Chelators Alone and in Combination with Azole and Polyene Antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother;536:2654-2656.